Fig. 11From: Network pharmacology and experimental verification-based strategy for exploring the mechanisms of luteolin in the treatment of osteosarcomaLuteolin inhibits proliferation and metastasis in orthotopic OS models. (A) The body weights of the two groups (n = 6 per group) intraperitoneally treated with or without luteolin. (B) IVIS imaging of OS orthotopic mouse model after different treatments (n = 6 per group). (C) The images of excised tumors in the two groups (n = 6 per group). (D) Representative luminescence images for the two groups. (E) Representative H&E staining images of tumor, lung, and liver. Scale bar = 100 μm. All data are expressed as mean ± SD, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 compared to the control group, respectivelyBack to article page